| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ARWR over the last quarter tilts toward selling: insiders offloaded a net 13,600 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $225.78M | - | |
| COO | 547.4K | $32.59M | - | |
| Other | 227.0K | $13.51M | - | |
| CFO | 162.9K | $9.70M | - | |
| Dir | 111.5K | $6.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | James C Hamilton58 | Chief Discovery/ Trans Medicine | Sell | 10,338 | $38.38 | $396,737.95 | -6.6% | -33.6% | -17.0% | |
| Dec 29, 2022 | Kenneth Allen Myszkowski68 | Chief Financial Officer | Sell | 30,625 | $40.00 | $1,225,000.00 | -8.3% | -38.3% | -23.7% | |
| Nov 21, 2022 | Martin Javier San65 | Chief Medical Officer | Sell | 19,500 | $29.99 | $584,738.00 | -17.6% | +6.5% | -4.9% | |
| Feb 11, 2022 | Christopher Richard Anzalone60 | Chief Executive Officer | Sale+OE | 146,388 | $51.91 | $7,598,864.47 | -3.5% | -40.2% | -34.6% | |
| Jan 5, 2022 | Patrick O'Brien76 | General Counsel | Sell | 32,500 | $61.72 | $2,005,875.26 | -8.5% | -19.6% | -38.4% | |
| Jan 5, 2022 | Kenneth Allen Myszkowski68 | Chief Financial Officer | Sell | 40,000 | $61.70 | $2,467,940.96 | -7.9% | -19.6% | -38.4% | |
| Jan 5, 2022 | James C Hamilton58 | Senior Vice President | Sell | 25,625 | $64.57 | $1,654,591.22 | -14.1% | -19.6% | -38.4% | |
| Jan 3, 2022 | Marianne De Backer67 | Director | Sell | 4,500 | $64.71 | $291,176.84 | -20.9% | -27.7% | -45.0% | |
| Jan 3, 2022 | Michael S Perry55 | Director | Sell | 4,500 | $64.71 | $291,192.40 | -5.0% | -27.7% | -45.0% | |
| Jan 3, 2022 | William D. Waddill | Director | Sell | 4,500 | $64.72 | $291,244.28 | -14.9% | -27.7% | -45.0% |